一种亲血管性免疫保护膜用于细胞疗法
Huifeng Wang1,2, Chongwen Duan1, Ruyue Luo1,2
1Department of Biomedical Engineering, Northwestern University, Evanston, IL, 60208, USA.
Advanced healthcare materials
|November 7, 2024
概括
一种新型的双重功能多孔膜可以保护移植细胞免受免疫攻击,并促进血管化. 这种免疫保护膜增强了移植疗法中的细胞活力和功能.
科学领域:
- 生物材料科学 生物材料科学
- 组织工程是组织工程.
- 免疫学 免疫学 免疫学
背景情况:
- 使用多孔膜进行免疫隔离对于细胞移植疗法至关重要.
- 当前的膜面临着平衡免疫保护与营养/氧气运输的挑战.
- 促进血管化是改善移植细胞生存和功能的关键.
研究的目的:
- 开发用于细胞移植的双重功能多孔聚合物膜.
- 为了实现免疫保护和增强血管化.
- 为了提高封装细胞的活力和功能.
主要方法:
- 制造具有 pore 尺寸梯度 (从纳米孔到微孔) 的双重功能多孔聚合物膜.
- 评估膜性质,包括细胞兼容性,T细胞转移,葡萄糖扩散和氧气透性.
- 在小鼠皮下植入模型的体内评估超过60天.
主要成果:
- 制造的膜表现出纳米孔向微孔的梯度.
- 证明了良好的细胞兼容性,并防止了T细胞的转移.
- 保持葡萄糖扩散和氧气透性.
- 在体内表现出60天的稳定性,减少纤维囊和增强血管化.
结论:
- 开发的多孔聚合物膜为细胞移植提供了双重功能.
- 这些膜提供免疫保护,并促进血管化,这对细胞生存至关重要.
- 在细胞移植疗法中潜在的应用,需要最大限度地提高细胞活力和功能.
更多相关视频
10:04The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro
Published on: September 18, 2017
11.0K
09:01Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
11.1K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
